DanielXu

Associate

Shanghai + 86.21.2201.8094

Daniel Xu advises corporate clients on cross-border M&A and investment transactions, with particular focus on foreign direct investments in China, outbound M&A by Chinese buyers, private equity, joint ventures, and other corporate matters. Daniel has advised clients from a wide range of industries such as media, automotive, education, health care, real estate, internet and high-tech, energy, and natural resources. He also has experience on acquisition and servicing of portfolios of nonperforming loans (NPLs).

Daniel's recent experience includes: Cardinal Health's $1.2 billion sale of its China business to Shanghai Pharmaceuticals Holding Co., Ltd.; advising Glencore Singapore Pte. Ltd. on the formation of Zhejiang Petroleum Trading Co., Ltd., a joint venture with Zhejiang Provincial Petroleum Co., Ltd.; advising a state-owned enterprise on its acquisition of a portfolio of PV solar generation facilities in California; advising a U.S. asset management company on their acquisition and servicing of distressed assets in China; and HNA's acquisition of a Hong Kong listed company.

Daniel is fluent in English and a native speaker of Mandarin Chinese.

Experience

  • Furukawa Electric and Superior Essex global joint venture finalizedJones Day advised Furukawa Electric Co., Ltd. in its finalization of a global joint venture with Superior Essex Inc.
  • Huadong Medicine enters co-development partnership with Exscientia to accelerate oncology drug discovery through AIJones Day advised Huadong Medicine Co. Ltd. in the negotiation and signing of a research cooperation agreement with Exscientia, a world-leading, clinical-stage Artificial Intelligence (AI) drug discovery company.
  • SunPower closes sponsored spin-off of solar panel production operationsJones Day advised SunPower Corporation (NASDAQ: SPWR), one of North America's largest solar-panel makers, in a sponsored spin-off of its solar panel production operations into a new public company – Maxeon Solar Technologies – which will be headquartered in Singapore.
  • Shanghai Zhenge Biotech raises $51 million in Series A roundJones Day represented Shanghai Zhenge Biotech Co., Ltd., a Shanghai-based CDMO (“Contract Development and Manufacturing Organization”) company for biotech companies developing antibodies and other protein drugs, in connection with the $51 million Series A round of financing led by LYFE Capital.
  • CWT sold Dongguan Hillview Golf Company to Hillview Holdings LimitedJones Day advised CWT International Limited, a public company listed in the Hong Kong Stock Exchange, in the HK$180 million sale of its 65% indirectly held equity interest in Dongguan Hillview Golf Company Limited to Hillview Holdings Limited.
  • HOERBIGER Group acquires Deublin CompanyJones Day advised HOERBIGER Group, a privately-held industrial company headquartered in Switzerland, on the acquisition of Deublin Company, the leading manufacturer of rotating unions in the world.
  • AURELIUS sells Solidus Solutions for €330 million (US$375.6 million)Jones Day advised AURELIUS Equity Opportunities SE & Co. KGaA on the full shop auction sale of the Solidus Solutions group to funds advised by Centerbridge Partners, L.P.
  • Huadong Medicine invests in R2 Dermatology and enters into distribution agreementJones Day advised Huadong Medicine Co. Ltd., a Chinese manufacturer and distributor of pharmaceutical and other medical products, in connection with its subscription of Series B Preferred Shares of R2 Dermatology, Inc., and the negotiation of a distribution agreement authorizing Huadong Medicine as an exclusive distributor in Asia for R2's skin whitening products.
  • UPL acquires Arysta LifeScience from Platform Specialty Products Corporation for $4.2 billionJones Day advised UPL Limited ("UPL"), a leading global generic agrochemical company based in India, in connection with its subsidiary, UPL Corporation Limited’s, US$4.2 billion acquisition and related $3 billion term financing of Arysta Lifescience Inc. (“Arysta”), a global provider of crop protection solutions, including bio-solutions and seed treatment, from NYSE listed Platform Specialty Products Corporation (“Platform”).
  • INVISTA sells Apparel & Advanced Textiles business to Shandong Ruyi Investment HoldingJones Day advised INVISTA, a subsidiary of Koch Industries, Inc., in its sale of INVISTA’s Apparel & Advanced Textiles business to Shandong Ruyi Investment Holding.
  • Molex acquires Laird Connected Vehicle Solutions divisionJones Day advised Molex Electronic Technologies, LLC, a leading global manufacturer of electronic solutions, on its acquisition of the Connected Vehicle Solutions division of Laird Limited.
  • Huadong Medicine announces £169 million (US$222 million) takeover offer for and acquisition of Sinclair Pharma PlcJones Day advised Huadong Medicine Co. Ltd. ("HMC") and its subsidiary, Huadong Medicine Aesthetics Investment (HongKong) Limited ("Huadong"), on Huadong's takeover offer for and acquisition of Sinclair Pharma Plc with a total value of approximately £169 million (US$222 million).
  • Riverside acquires majority stake in AbraconJones Day represented The Riverside Company in connection with the acquisition and related financing of a majority stake in Abracon, a Texas-based global provider of passive and electromechanical timing, synchronization, power, connectivity and radio frequency (RF) solutions from Evergreen Pacific Partners.
  • U.S. university establishes office in ShanghaiJones Day assisted a state university in establishing and operating a representative office in the city of Shanghai, China.
  • Sequoia China invests in HiFiBiO TherapeuticsJones Day represented Sequoia China in connection with its purchase of Series B Convertible Preferred Stock in a private placement by HiFiBiO Therapeutics, a world leader in the discovery of therapeutic antibodies through single-B-cell screening and analysis.
  • Lennox International sells refrigeration businesses in Australia, New Zealand, and Asia to Beijer Ref ABJones Day advised Lennox International Inc. in the sale of its refrigeration businesses in Australia, New Zealand, and Asia to Beijer Ref AB.
  • Glencore Singapore forms joint venture with Zhejiang Provincial PetroleumJones Day advised Glencore Singapore Pte. Ltd. on the formation of Zhejiang Petroleum Trading Co., Ltd., a joint venture with Zhejiang Provincial Petroleum Co., Ltd.
  • New Enterprise Associates invests in TuyaJones Day represented New Enterprise Associates in connection with its investment in Tuya Inc., a China-based technology company.
  • Cardinal Health sells its Cardinal Health China distribution business to Shanghai Pharmaceuticals for $1.2 billionJones Day advised Cardinal Health in the $1.2 billion sale of its Cardinal Health China distribution business to Shanghai Pharmaceuticals Holding Co., Ltd.
  • Shenzhen Energy Group acquires PV solar generation facilities from Recurrent Energy for $232 millionJones Day advised Shenzhen Energy Group Co., Ltd. on its $232 million acquisition of a portfolio of PV solar generation facilities in California from Recurrent Energy, a wholly owned U.S. subsidiary of Canadian Solar.
  • We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.